These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 1586239
1. Increased risk of cancer in patients with systemic lupus erythematosus. Pettersson T, Pukkala E, Teppo L, Friman C. Ann Rheum Dis; 1992 Apr; 51(4):437-9. PubMed ID: 1586239 [Abstract] [Full Text] [Related]
2. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up. Tallbacka KR, Pettersson T, Pukkala E. Scand J Rheumatol; 2018 Nov; 47(6):461-464. PubMed ID: 29318934 [Abstract] [Full Text] [Related]
3. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Arthritis Rheum; 1997 Apr; 40(4):761-8. PubMed ID: 9125261 [Abstract] [Full Text] [Related]
4. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. Sultan SM, Ioannou Y, Isenberg DA. Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137 [Abstract] [Full Text] [Related]
5. An international cohort study of cancer in systemic lupus erythematosus. Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Petri M, Edworthy S, Barr S, Gordon C, Bae SC, Sibley J, Isenberg D, Rahman A, Aranow C, Dooley MA, Steinsson K, Nived O, Sturfelt G, Alarcón G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, El-Gabalawy H, McCarthy T, St Pierre Y, Ramsey-Goldman R, Clarke A. Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596 [Abstract] [Full Text] [Related]
6. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Löfström B, Backlin C, Sundström C, Ekbom A, Lundberg IE. Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757 [Abstract] [Full Text] [Related]
7. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. Dreyer L, Faurschou M, Mogensen M, Jacobsen S. Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088 [Abstract] [Full Text] [Related]
9. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Björnådal L, Löfström B, Yin L, Lundberg IE, Ekbom A. Scand J Rheumatol; 2002 Jun; 31(2):66-71. PubMed ID: 12109649 [Abstract] [Full Text] [Related]
10. Risk of malignancy in women with systemic lupus erythematosus. Sweeney DM, Manzi S, Janosky J, Selvaggi KJ, Ferri W, Medsger TA, Ramsey-Goldman R. J Rheumatol; 1995 Aug; 22(8):1478-82. PubMed ID: 7473469 [Abstract] [Full Text] [Related]
11. Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Kang KY, Kim HO, Yoon HS, Lee J, Lee WC, Ko HJ, Ju JH, Cho CS, Kim HY, Park SH. Clin Rheumatol; 2010 Apr; 29(4):381-8. PubMed ID: 20041274 [Abstract] [Full Text] [Related]
12. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Chen YJ, Chang YT, Wang CB, Wu CY. Am J Med; 2010 Dec; 123(12):1150.e1-6. PubMed ID: 21183006 [Abstract] [Full Text] [Related]
13. Systemic lupus erythematosus and the risk of malignancy. Cibere J, Sibley J, Haga M. Lupus; 2001 Dec; 10(6):394-400. PubMed ID: 11434573 [Abstract] [Full Text] [Related]
14. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus. Ragnarsson O, Gröndal G, Steinsson K. Lupus; 2003 Dec; 12(9):687-91. PubMed ID: 14514131 [Abstract] [Full Text] [Related]
15. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden. Nived O, Bengtsson A, Jönsen A, Sturfelt G, Olsson H. Lupus; 2001 Dec; 10(7):500-4. PubMed ID: 11480849 [Abstract] [Full Text] [Related]
17. Patients with systemic lupus erythematosus (SLE) having developed malignant lymphomas. Complete remission of lymphoma following high-dose chemotherapy, but not of SLE. Rossi E, Catania G, Truini M, Ravetti GL, Grassia L, Marmont AM. Clin Exp Rheumatol; 2011 Dec; 29(3):555-9. PubMed ID: 21722503 [Abstract] [Full Text] [Related]